title: Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.
abstract: Over 1 million men undergo biopsy in the United States each year to evaluate for prostate cancer (S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker, and E. M. Schaeffer, J Urol 186:1830-1834, 2011, http://dx.doi.org/10.1016/j.juro.2011.06.057). In recent years, there has been a rise in infectious complications related to these procedures. This review aims to provide an overview of the guidelines that direct transrectal prostate biopsy, to describe associated infection, and to evaluate the published data driving the current trend toward prebiopsy screening for resistant organisms.
authors.affiliation: Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri, USA rchambe6@slu.edu.
authors.forename: Robin R
authors.initials: RR
authors.lastname: Chamberland
mesh_terms: D001424:Bacterial Infections / Q000175:diagnosis / Q000382:microbiology / Q000517:prevention & control*; D001706:Biopsy / Q000009:adverse effects* / Q000379:methods*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D017410:Practice Guidelines as Topic; D011300:Preoperative Care / Q000379:methods*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D014481:United States